«Malabsorption Syndromes

Below is an extended Malabsorption Syndromes patents listing. Click here to return to the Malabsorption Syndromes main in depth entry.

Patents :
US Patent No.	Title
6951850	Dipeptide derivatives
7081239	Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
7087395	Vitamin D assay
7091315	Protein HDPBQ71
7094565	21612, novel human dehydrogenases
7112567	Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
7128911	Antigen arrays for treatment of bone disease
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7163797	50 human secreted proteins
7189690	Albumin fusion proteins
7196164	Secreted protein HHTLF25
7060476	27411, a novel human PGP synthase
7049284	Glucagon-like peptide-2 and its therapeutic use
7041474	Nucleic acid encoding human tango 509
6951924	Antibodies against secreted protein HTEBYII
6953682	Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
6953791	Dipeptide derivatives
6994095	Pyloric valve corking device and method
6994857	Albumin fusion proteins
7026294	Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
7026298	Oral rehydration compositions
7026447	53 human secreted proteins
7029895	27411, a novel human PGP synthase
7037671	25312, a novel human agmatinase-like homolog
7202029	Nucleic acids encoding human TANGO 195
7217687	Use of osteopontin for the treatment and/or prevention of neurologic diseases
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7371727	Methods and compositions for the treatment of gastrointestinal disorders
7381800	Antibodies to HBIMF63 polypeptide
7385036	Human tango 509 polypeptides
7393849	Substituted sulfonamides and ureas useful for inhibiting kinase activity
7399740	Poly-Glu,Tyr for neuroprotective therapy
7407936	Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy
7408038	Secreted immunomodulatory proteins
7411051	Antibodies to HDPPA04 polypeptide
7348140	Clinical indications for genotyping polymorphic variants of G-protein coupled receptors
7329529	Ubiqutin proteases
7323457	Substituted sulfonamides and ureas useful for inhibiting kinase activity
7223763	Substituted sulfonamides and ureas useful for inhibiting kinase activity
7232667	Keratinocyte growth factor-2 polynucleotides
7238660	Albumin fusion proteins
7238667	Albumin fusion proteins
7244412	Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
7259234	Stable analogs of peptide and polypeptide therapeutics
7288392	Human protein kinases and uses therefor
7297099	Use of osteopontin for the treatment and/or prevention of neurologic diseases
7301016	Human transferase family members and uses thereof
7304036	Methods and compositions for the treatment of gastrointestinal disorders
7411054	25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.